We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Artsana Warned by FDA for Complaint Handling, cGMP Issues
Artsana Warned by FDA for Complaint Handling, cGMP Issues
July 7, 2011
Syringe manufacturer Artsana was cited for various cGMP violations, including improper complaint handling procedures, in an FDA warning letter recently made available to the public.